UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer
Preprint in Research Square (July 2022)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis
Article in Cellular Oncology (July 2022)
Multi-Omics Analysis After Vaginal Administration of Bacteroides fragilis in Chickens
Article in Frontiers in Microbiology (February 2022)